visitant ::
identificació
|
|||||||||||||||
Cerca | Lliura | Ajuda | Servei de Biblioteques | Sobre el DDD | Català English Español |
Pàgina inicial > Articles > Articles publicats > In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease : |
Data: | 2021 |
Resum: | Introduction: We aimed to assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) integrity and cognition in Parkinson's disease (PD) without dementia. Methods: The study included a total of 180 non-demented PD patients and 45 healthy controls, who underwent structural MRI acquisitions and standardized neurocognitive assessment through the PD-Cognitive Rating Scale (PD-CRS) within the multicentric COPPADIS-2015 study. A subset of 73 patients also had Diffusion Tensor Imaging (DTI) acquisitions. Volumetric and microstructural (mean diffusivity, MD) indices of CBF degeneration were automatically extracted using a stereotactic CBF atlas. For comparison, we also assessed multimodal indices of hippocampal degeneration. Associations between imaging measures and cognitive performance were assessed using linear models. Results: Compared to controls, CBF volume was not significantly reduced in PD patients as a group. However, across PD patients lower CBF volume was significantly associated with lower global cognition (PD-CRS: r = 0. 37, p < 0. 001), and this association remained significant after controlling for several potential confounding variables (p = 0. 004). Analysis of individual item scores showed that this association spanned executive and memory domains. No analogue cognition associations were observed for CBF MD. In covariate-controlled models, hippocampal volume was not associated with cognition in PD, but there was a significant association for hippocampal MD (p = 0. 02). Conclusions: Early cognitive deficits in PD without dementia are more closely related to structural MRI measures of CBF degeneration than hippocampal degeneration. In our multicentric imaging acquisitions, DTI-based diffusion measures in the CBF were inferior to standard volumetric assessments for capturing cognition-relevant changes in non-demented PD. |
Ajuts: | Instituto de Salud Carlos III PI14/01823 Instituto de Salud Carlos III PI16/01575 Instituto de Salud Carlos III PI18/01898 Instituto de Salud Carlos III PI19/01576 Instituto de Salud Carlos III PI20/00613 Instituto de Salud Carlos III CP19/00031 Instituto de Salud Carlos III CD13/00229 Instituto de Salud Carlos III CM18/00142 |
Nota: | Altres ajuts: Alzheimer Forschung Initiative (AFI International Training Grant to MJG); Fondo Europeo de Desarrollo Regional (FEDER); Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685); Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019); Fundación Alicia Koplowitz; Fundación "Curemos el Parkinson" (https://www.curemoselparkinson.org); Universidad de Sevilla (USE-20046-J, USE-18817-A); Programa Acción B-Clínicos-Investigadores (B-0007-2019). |
Drets: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. |
Llengua: | Anglès |
Document: | Article ; recerca ; Versió publicada |
Matèria: | Nucleus basalis Meynert ; Substantia innominata ; MRI ; DTI ; Diffusion ; Parkinson's disease |
Publicat a: | Parkinsonism and Related Disorders, Vol. 88 (july 2021) , p. 68-75, ISSN 1873-5126 |
8 p, 657.2 KB |